A Study to Investigate the Long-term Safety and Efficacy of Tolvaptan in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Trial 156-04-251 in Japan]
This study is ongoing, but not recruiting participants.
Study NCT01280721
Information provided by Otsuka Pharmaceutical Co., Ltd.
First Received on December 6, 2010.
Last Updated on April 23, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
